Robust Kv7 voltage gated potassium ion channel profiling for confident compound selection

Data Card

Metrion combines robust high-throughput Kv7 assay capability with deep ion channel expertise to help biotech and pharma teams advance programmes in pain and epilepsy with confidence.Metrion combines robust high-throughput KV7 assay capability with deep expertise in voltage gated potassium ion channels to help biotech and pharma teams advance programmes in pain and epilepsy with confidence.

Metrion delivers scalable KV7 IV profiling with the data quality and scientific support needed to advance ion channel programmes efficiently.

Frequently asked questions

What is a KV7 channel?

What is epilepsy?

Why are KV7 channels relevant to epilepsy?


Recommended Publications
Latest Publications
Simultaneous assessment of current response and ΔV½ enables sensitive characterisation of KV7 modulators across screening and profiling workflows

Reliable, high-throughput KV7 assays paired with expert interpretation enable faster progression of pain and epilepsy drug discovery programmes.

Activation of TREK-1 and TREK-2 Two-Pore Domain Potassium Channels by the Kv4 Channel Modulator, NS5806

NS5806, widely used as a Kv4-selective activator, also activates TREK-1 and TREK-2 potassium channels.

View All
Activation of TREK-1 and TREK-2 Two-Pore Domain Potassium Channels by the Kv4 Channel Modulator, NS5806
Future-proof cardiac safety: Scalable hiPSC cardiomyocyte new approach methodologies (NAMs) that de-risk earlier and strengthen IND packages
View All
Metrion is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
Copyright © 2024 Metrion. All rights reserved | Privacy notice | Registered as a company in England and Wales: 09669815 | VAT: GB 219828479
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram